REV

Recent Articles

Nu Skin Doesn’t Deliver Enough for Investors

Nu Skin develops and distributes anti-aging personal care products worldwide, and I have some concerns about the stock as a strong dividend play More 

L’Oreal Looks Younger With Urban Decay

L'Oreal has been making moves left and right lately, most recently striking a small-but-inspiring deal for edgy cosmetics company Urban Decay. More 

5 Reasons to Get a Whiff of Coty’s IPO

Coty -- maker of fragrances by Calvin Klein, Marc Jacobs and more -- recently announced a $700 million IPO. Check out these five reasons why it looks promising. More 

Beauty Stocks: 3 to Buy, 3 to Leave

This month has been wild for beauty shares. It's time to turn to the Socratic principle: Question everything. More 

10 Stocks to Watch Get Ready to Release Earnings

Earnings releases from 10 key stocks can effect your portfolio decisions, so keep an eye on them over the next two days. More 

Sheri McCoy Takes Charge at Avon

The J&J veteran is coming in at a crucial moment, just a week after Avon rejected a $10 billion takeover bid from Coty. More 

Avon Surges on CEO Change — But AVP Stock Still Shaky

AVP stock might look good after a leadership change and with a 5% dividend, but Andrea Jung's replacement will be fighting SEC investigations, other issues. More